SkyCell, based in Switzerland, has closed $116M in a Series D round for its technological solution that improves the pharmaceutical supply chain for air travel. Founded in 2013, the startup manufactures temperature-controlled containers, using proprietary cold chain technology to monitor and optimise functions such as cooling, humidity protection, and shock absorption. The containers also come with a patented insulation system that reflects heat radiation, enabling them to self-charge in cold environments such as refrigerated vehicles. This ensures a steady temperature between -80°C to 25°C, depending on the specific model. Effective cold chain storage has become a critical part of pharma…
This story continues at The Next Web
